Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
filingDate |
1999-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8926870f2c375d9f1a1ea23842f0ede2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a5c9e70cc0ca2a3b8722ae5430c4e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c152a3353de91f0f44ec903a75266777 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6902b075280bbf6d01997bcc278f7093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e11cc017f8348fbb26a67982097b4ce3 |
publicationDate |
2001-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-449476-B |
titleOfInvention |
Anticonvulsive and antiallergic/antiasthmatic pyrazolo-[3,4-d]pyrimidines having affinity for the adenosine receptor, and process for their preparation |
abstract |
The invention relates to pyrazolo [3,4-d] pyrimidin-4(5H)-ones and pyrazolo [3,4-d] pyrimidine-4(5H)-thiones and their tautomers which contain a benzyl radical in the 2-position, processes for their preparation and their use as medicaments, in particular for the treatment of epilepsies of various forms and of allergic/asthmatic diseases. |
priorityDate |
1998-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |